Cayman Chemical PAD4 Inhibitor Screening Assay Kit (Ammonia)

Wednesday, 21 March, 2018 | Supplied by: Sapphire Bioscience

Cayman Chemical’s PAD4 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method for screening human inhibitors of protein arginine deiminase 4 (PAD4), a guanidino-modifying enzyme that functions as a transcriptional co-regulator catalysing the conversion of specific arginine residues to citrulline.

PAD4 autocitrullinates itself at several sites, inhibiting its enzymatic activity. PAD4 activity is increased in rheumatoid arthritis, producing an abundance of citrulline-containing proteins that generate an immune response resulting in production of autoantibodies that ultimately attack the host tissues. PAD4 has also been implicated in several other diseases including multiple sclerosis, Alzheimer’s disease, glaucoma and cancer.

PAD4 results in the deimination of N-α-benzoyl-L-arginine ethyl ester (BAEE), a non-natural substrate with similar kinetic properties to the natural substrates, producing ammonia. Ammonia reacts with a detector resulting in a fluorescent product. Fluorescence is then analysed with an excitation wavelength of 405–415 nm and an emission wavelength of 470–480 nm.

Phone: 02 9698 2022
Related Products

Enzo Life Sciences AMPINEXT DNA Library Preparation Kit (Illumina)

The AMPINEXT DNA Library Preparation Kit (Illumina), from Enzo Life Sciences, is a complete set...

Agilent BenchCel Microplate Handler

The Agilent BenchCel Microplate Handler is a compact microplate storage and automated microplate...

Enzo Life Sciences SARS-CoV-2 IgG ELISA kit

Enzo's ELISA assay is a qualitative assay optimised to provide sensitive detection of IgG...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd